Literature DB >> 35422898

Long non-coding RNA UCA1 promotes retinoblastoma progression by modulating the miR-124/c-myc axis.

Lan Wang1,2, Mingxing Wu1, Xiyuan Zhou1.   

Abstract

The long non-coding RNA (lncRNA), urothelial carcinoma-associated 1 (UCA1), belongs to cancer-related lncRNAs implicated in various carcinomas, including colorectal and gastric cancers. Nonetheless, the role and underlying mechanisms of UCA1 in retinoblastoma are still unclear. This study found that UCA1 expression in retinoblastoma tissues and cells was dramatically upregulated relative to that of healthy controls. Functionally, UCA1 knockdown could suppress retinoblastoma cells' proliferation, migration and invasion, and facilitate their apoptosis. Knockdown of UCA1 also retarded the growth of xenograft tumors in vivo. Mechanistically, UCA1 promoted c-myc expression through sponging miR-124. miR-124 inhibition or c-myc overexpression partially reversed the effects of UCA1 knockdown on retinoblastoma cells. Overall, lncRNA UCA1 may exert an oncogenic effect on retinoblastoma progression through the miR-124/c-myc axis, which might serve as a promising retinoblastoma treatment target. AJTR
Copyright © 2022.

Entities:  

Keywords:  Retinoblastoma; c-myc; miR-124; tumorigenesis; urothelial carcinoma-associated 1

Year:  2022        PMID: 35422898      PMCID: PMC8991135     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  41 in total

1.  Silence of lncRNA ANRIL represses cell growth and promotes apoptosis in retinoblastoma cells through regulating miR-99a and c-Myc.

Authors:  Xiaomin Wang; Xinxia Zhang; Yutong Han; Qiuli Wang; Yanfan Ren; Baojun Wang; Junxi Hu
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

2.  Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.

Authors:  Margaritis Avgeris; Anastasia Tsilimantou; Panagiotis K Levis; Theodoros Rampias; Maria-Alexandra Papadimitriou; Konstantina Panoutsopoulou; Konstantinos Stravodimos; Andreas Scorilas
Journal:  Carcinogenesis       Date:  2019-08-22       Impact factor: 4.944

3.  Clinical Application of Long Non-Coding RNA-UCA1 as a Candidate Gene in Progression of Esophageal Cancer.

Authors:  Hamid Aalijahan; Saeid Ghorbian
Journal:  Pathol Oncol Res       Date:  2019-08-14       Impact factor: 3.201

4.  miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.

Authors:  Shu Liu; Chunmei Hu; Yingxue Wang; Guang Shi; Yarong Li; Huang Wu
Journal:  Oncol Rep       Date:  2016-08-03       Impact factor: 3.906

5.  RETRACTED: Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p.

Authors:  Chunling Xu; Chunmei Hu; Yingxue Wang; Shu Liu
Journal:  Biomed Pharmacother       Date:  2019-06-21       Impact factor: 6.529

Review 6.  Retinoblastoma.

Authors:  Michael V Ortiz; Ira J Dunkel
Journal:  J Child Neurol       Date:  2015-05-28       Impact factor: 2.363

7.  Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.

Authors:  Roshan Fatima; Vijay Suresh Akhade; Debosree Pal; Satyanarayana Mr Rao
Journal:  Mol Cell Ther       Date:  2015-06-12

Review 8.  Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.

Authors:  Inés Mármol; Cristina Sánchez-de-Diego; Alberto Pradilla Dieste; Elena Cerrada; María Jesús Rodriguez Yoldi
Journal:  Int J Mol Sci       Date:  2017-01-19       Impact factor: 5.923

9.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.

Authors:  Angie M Cheng; Mike W Byrom; Jeffrey Shelton; Lance P Ford
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

10.  miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer.

Authors:  Feng Liu; Hongjuan Hu; Jianfu Zhao; Zhiwei Zhang; Xiaohong Ai; Liyun Tang; Liming Xie
Journal:  Biomed Rep       Date:  2018-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.